• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Commun Biol . Characterization of an unusual SARS-CoV-2 main protease natural variant exhibiting resistance to nirmatrelvir and ensitrelvir

tetano

Editor, Senior Moderator
Commun Biol


. 2025 Jul 17;8(1):1061.
doi: 10.1038/s42003-025-08487-w. Characterization of an unusual SARS-CoV-2 main protease natural variant exhibiting resistance to nirmatrelvir and ensitrelvir

Dipendra Bhandari[SUP] 1 [/SUP], Oksana Gerlits[SUP] 2 [/SUP], Stephen Keable[SUP] 1 [/SUP], Leighton Coates[SUP] 3 [/SUP], Annie Aniana[SUP] 4 [/SUP], Rodolfo Ghirlando[SUP] 5 [/SUP], Nashaat T Nashed[SUP] 4 [/SUP], Andrey Kovalevsky[SUP] 6 [/SUP], John M Louis[SUP] 7 [/SUP]



Affiliations
Abstract

We investigate the effects of two naturally selected substitution and deletion (Δ) mutations, constituting part of the substrate binding subsites S2 and S4, on the structure, function, and inhibition of SARS CoV-2 main protease. Comparable to wild-type, MPro[SUP]D48Y/ΔP168[/SUP] undergoes N-terminal autoprocessing essential for stable dimer formation and mature-like catalytic activity. The structures are similar, but for an open active site conformation in MPro[SUP]D48Y/ΔP168[/SUP] and increased dynamics of the S2 helix, S5 loop, and the helical domain. Some dimer interface contacts exhibit shorter H bond distances corroborating the ~40-fold enhanced dimerization of the mutant although its thermal sensitivity to unfolding is 8 °C lower, relative to wild-type. ITC reveals a 3- and 5-fold decrease in binding affinity for nirmatrelvir and ensitrelvir, respectively, and similar GC373 affinity, to MPro[SUP]D48Y/ΔP168[/SUP] relative to wild-type. Structural differences in four inhibitor complexes of MPro[SUP]D48Y/ΔP168[/SUP] compared to wild-type are described. Consistent with enhanced dynamics, the S2 helix and S5 loop adopting a more open conformation appears to be a unique feature of MPro[SUP]D48Y/ΔP168[/SUP] both in the inhibitor-free and bound states. Our results suggest that mutational effects are compensated by changes in the conformational dynamics and thereby modulate N-terminal autoprocessing, K[SUB]dimer[/SUB], catalytic efficiency, and inhibitor binding.


 
Back
Top Bottom